Access Restriction

Author Schiza, Sophia ♦ Torre, Olga ♦ Visca, Dina ♦ Harari, Sergio ♦ Poletti, Venerino ♦ Bouloukaki, Isolde ♦ Daniil, Zoi ♦ Sourvinos, George ♦ Mermigkis, Charalampos ♦ Margaritopoulos, George A. ♦ Renzoni, Elizabetta A. ♦ Antoniou, Katerina M.
Source Directory of Open Access Journals (DOAJ)
Content type Text
Publisher European Respiratory Society
File Format HTM / HTML
Date Created 2015-06-03
Copyright Year ©2015
Language English
Subject Domain (in LCC) RC705-779
Subject Keyword Diseases of the respiratory system ♦ Internal medicine ♦ Medicine ♦ Specialties of internal medicine
Abstract The prevalence of obstructive sleep apnoea (OSA) is continuously increasing in patients with idiopathic pulmonary fibrosis (IPF) and, for the first time, the recent IPF guidelines recognise OSA as an important associated comorbidity that can affect patient's survival. Thus, it becomes conceivable that clinicians should refer patients with newly diagnosed IPF to sleep centres for the diagnosis and treatment of OSA as well as for addressing issues regarding the reduced compliance of patients with continuous positive airway pressure therapy. The discovery of biomarkers common to both disorders may help early diagnosis, institution of the most appropriate treatment and follow-up of patients. Better understanding of epigenetic changes may provide useful information about pathogenesis and, possibly, development of new drugs for a dismal disease like IPF.
ISSN 16000617
Age Range 18 to 22 years ♦ above 22 year
Educational Use Research
Education Level UG and PG ♦ Career/Technical Study
Learning Resource Type Article
Publisher Date 2015-06-01
e-ISSN 09059180
Journal European Respiratory Review
Volume Number 24
Issue Number 136
Page Count 13
Starting Page 327
Ending Page 339

Source: Directory of Open Access Journals (DOAJ)